Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-010721
Filing Date
2020-04-14
Accepted
2020-04-14 17:01:02
Documents
2
Period of Report
2020-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2141
2 EX-24 DOCUMENT attachment1.htm EX-24 3540
  Complete submission text file 0000899243-20-010721.txt   7170
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MEDIVATION, INC. 201 SPEAR ST., 3RD FLOOR SAN FRANCISCO CA 94105
Business Address
Cohen Cheryl (Reporting) CIK: 0001529371 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50484 | Film No.: 20791824